Quantcast
Channel: MassDevice
Browsing all 11515 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Staar Surgical wins Health Canada nod as shares hit 52-week low

Implantable contact lens maker Staar Surgical (NSDQ:STAA) said it earned Health Canada approval to sell its EVO Visian ICL in the country. The device to correct myopia and astigmatism is permanently...

View Article



Image may be NSFW.
Clik here to view.

Biostage unveils $5 million offering for organ regeneration tech

Organ regeneration specialist Biostage (NSDQ:BSTG), formerly know as Harvard Apparatus Regenerative Technology, announced that it will offer $5 million worth of common stock May 19 to fund its ongoing...

View Article

Image may be NSFW.
Clik here to view.

Mitralign drums up $40m Series E for heart valve repair devices

Mitralign said today that it raised a Series E round worth nearly $40 million for a pair of heart valve repair devices, its namesake Mitralign annuloplasty system and the Trialign device for tricuspid...

View Article

Image may be NSFW.
Clik here to view.

Renal Dynamics launches post-market trial for Redy 3rd-gen renal denervation...

Renal Dynamics said it launched a post-market study of its Redy renal denervation device for treating hypertension, after winning CE Mark approval for the device last November. Zug, Switzerland-based...

View Article

Image may be NSFW.
Clik here to view.

Report: GE Healthcare CEO Flannery turns his eye from M&A to internal growth

GE Healthcare (NYSE:GE) CEO John Flannery, who oversaw more than $26 billion in deals during his tenure as the conglomerate’s business development leader, is reportedly looking to a different playbook...

View Article


Image may be NSFW.
Clik here to view.

Johnson & Johnson, HP ink medical 3D printing deal

  Johnson & Johnson (NYSE:JNJ) said today it inked a deal between its J&J Services biz and a subsidiary of HP to collaborate on using 3D printing tech to create “better health care outcomes at...

View Article

Image may be NSFW.
Clik here to view.

Grifols puts up $50m for 20% stake in Singulex

Grifols (NSDQ:GRFS) said today it invested $50 million in clinical diagnostic tech developer Singulex, giving Grifols a 20% stake in the company. Grifols’ investment in Singulex now has a fully-diluted...

View Article

Image may be NSFW.
Clik here to view.

MassDevice.com +5 | The top 5 medtech stories for May 17, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...

View Article


Image may be NSFW.
Clik here to view.

BTG Group FY profit doubles, sees 8-15% rev growth

(Reuters) – British healthcare group BTG (LON:BTG) said its full-year pretax profit doubled from a year earlier as sales of its interventional therapies picked up, and forecast an 8-15% revenue growth...

View Article


Image may be NSFW.
Clik here to view.

Philips and Profound Medical extend ablation tech deal

Royal Philips (NYSE:PHG) said it extended its deal with Profound Medical to include a sales and marketing agreement to promote Profounds’ Tulsa-Pro ultrasound ablation system. Profounds Tulsa system...

View Article

Image may be NSFW.
Clik here to view.

Pentax Medical picks up controlling shares in Simmedica.

Hoya (TYO:7741) subsidiary Pentax Medical said today it acquired over 90% of the shares in Spanish and Portugeuese endoscopy and surgery product and service company Simmedica. Pentax Medical said it...

View Article

Image may be NSFW.
Clik here to view.

ReWalk inks collab deal with Harvard to develop “soft” exosuit

ReWalk Robotics (NSDQ:RWLK) said today it inked a collaborative research with Harvard’s Wyss Institute to develop a lightweight “soft suit” exoskeleton system for lower limb disabilities. The...

View Article

Image may be NSFW.
Clik here to view.

Digital “fingerprint” for medical devices could help thwart hackers

As security becomes more and more important in medical device development groups are turning to new systems that create “fingerprints” for trusted devices to lock out invasive forces, according to a...

View Article


Image may be NSFW.
Clik here to view.

Mazor Robotics inks $42m deal with Medtronic

Mazor Robotics (NSDQ:MZOR) said today that it inked a 2-phase deal with Medtronic (NYSE:MDT) for its robot-assisted spine surgery technology that includes a co-promotion agreement and an equity...

View Article

Image may be NSFW.
Clik here to view.

US FDA issues technical guidance for medical devices using 3-D printing

By Stewart Eisenhart, Emergo Group New draft guidance from the US Food and Drug Administration covers premarket and quality system issues concerning medical devices incorporating additive manufacturing...

View Article


Image may be NSFW.
Clik here to view.

Smith & Nephew deals Truclear gynecology biz to Medtronic for $350m

Smith & Nephew (NYSE:SNN) said today that it’s dealing its gynecology business to Medtronic (NYSE:MDT), including the Truclear hysteroscopic resection and removal system, for $350 million. The...

View Article

Image may be NSFW.
Clik here to view.

Zimmer Biomet closes Cayenne Medical buy

Zimmer Biomet (NYSE:ZBH) said today that it closed its buyout of Cayenne Medical and its soft tissue reconstruction devices for an unspecified amount. Scottsdale, Ariz.-based Cayenne makes devices for...

View Article


Image may be NSFW.
Clik here to view.

Teleflex closes $400m debt offering

Teleflex (NYSE:TFX) said Monday it closed a $400 million debt offering round through the offering of 4.875% senior notes due in 2026. The Wayne, Penn.-based company said it expects to net approximately...

View Article

Image may be NSFW.
Clik here to view.

U.S. trial test machine that ‘reconditions’ lungs outside body

(Reuters) – A machine that ‘reconditions’ a donor’s lungs outside the body before being transplanted into a recipient is undergoing tests in the United States in the hope that it can radically improve...

View Article

Image may be NSFW.
Clik here to view.

Edwards touts multi-trial heart valve data

Edwards Lifesciences (NYSE:EW) yesterday released results from 3 trials of its surgical heart valves designed for treating aortic valve disease, touting positive clinical results from studies of over...

View Article
Browsing all 11515 articles
Browse latest View live




Latest Images